A group of 18 physician voting members, commissioned by the National Psoriasis Foundation (NPF), developed a scientifically based guidance to promote the optimal management of psoriatic disease during the COVID-19 pandemic. A paper regarding the task force's consensus and process was published online in the Journal of the American Academy of Dermatology.
In total, 22 guidance statements had 100% complete voting. All 22 statements were recommended, with 9 having high consensus and 13 having moderate consensus. The guidance statements can be accessed on the NPF website.
What were some of their recommendations? Take our quiz below!
Dr Joel Gelfand, senior advisor of the Interdisciplinary Autoimmune Summit and cochair of the NPF COVID-19 Task Force, discussed some of his clinical experiences and recommendations based on the Task Force's guidance in the video below!
